Thu, June 6, 2024

Michelle Gilson Maintained (VIR) at Hold with Increased Target to $15 on, Jun 6th, 2024

Michelle Gilson of Morgan Stanley, Maintained "Vir Biotechnology, Inc." (VIR) at Hold with Increased Target from $12 to $15 on, Jun 6th, 2024.

Michelle has made no other calls on VIR in the last 4 months.



There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $12 on, Friday, May 3rd, 2024


These are the ratings of the 2 analyists that currently disagree with Michelle


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $19 on, Wednesday, June 5th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $110 on, Wednesday, June 5th, 2024